The two groups did not have significant difference in terms of gender, body mass index, genotypes, HCV RNA viral load, ALT level, DAA therapy duration, presence of diabetes mellitus, fatty liver, SVR rate, or previous anti-viral treatment history. The gene discussed is GPT; the disease is diabetes mellitus.